Effects of interferons on proliferation and collagen synthesis of rat palatal wound fibroblasts
Introduction
Scar formation after cleft palate surgery is one of the major factors causing aberrant maxillary growth and dento-alveolar development (Ross, 1987). Consequently, the inhibition of scar formation seems a feasible way of improving the clinical outcome.
Tissue injury triggers a complex cascade of cellular and biochemical events that finally results in a scar. After injury, there is inflammation, fibroblast proliferation, matrix synthesis and remodelling (Witte and Barbul, 1997). Every phase contributes to the amount of scarring by influencing the rate, quality and total amount of matrix deposition. Oral palatal wounds also pass through these phases of wound healing (Kahnberg and Thilander, 1982). The number of collagen fibres in palatal mucoperiosteal wounds is increased up to 4 weeks after wounding (Searls et al., 1979). This seems to be due not only to an increased number of cells but also to an increase in collagen production per cell (Moriyama et al., 1991).
A comparison of adult and foetal wound healing has shown that foetal wounds heal without scarring (Longaker and Adzick, 1991). This has been attributed to a lower inflammatory response (Whitby and Ferguson, 1991a) and a different cytokine profile (Whitby and Ferguson, 1991b), which suggests that manipulation of wound healing by altering the cytokine profile could lead to scarless healing. Only a few cytokines have been identified that have the potential to reduce scarring; interferons represent the first well-defined group of polypeptides that exert this property (Granstein et al., 1990a).
The ability of interferons to modulate wound healing has been studied in vivo and on a variety of cell types in vitro. IFN-α, IFN-β and IFN-γ reduce collagen synthesis by dermal fibroblasts (Duncan et al., 1995), hypertrophic scar fibroblasts (Tredget et al., 1993) and fibroblasts derived from sclerodermal lesions (Duncan and Berman, 1987). In vivo studies in mice have demonstrated that IFN-γ reduced the increased collagen synthesis associated with the fibrotic response to an implanted foreign body (Granstein et al., 1990a). This effect was also found in bleomycin-induced pulmonary fibrosis and the healing response to cutaneous burn wounds (Granstein et al., 1990a). The therapeutic relevance of these in vitro and in vivo observations has been confirmed in clinical trials. Intralesional injection of IFN-α2b (Berman and Duncan, 1989) or IFN-γ (Granstein et al., 1990b) reduced the sizes of keloid and hypertrophic scars (Larrabee et al., 1990).
The regulation of protein and collagen synthesis in normal fibroblasts by interferon in vitro depends on the anatomical site (Smith and Higgins, 1993, Martens et al., 1992). Moreover, dermal fibroblasts show a modulated response to IFN-γ according to their stage of differentiation during wound healing (Moulin et al., 1998). For wound healing factors such as migration (Irwin et al., 1994) and matrix remodelling (Stephens et al., 1996), it has been shown that there are phenotypic differences between dermal and oral fibroblasts. Therefore it is quite possible that there are differences in the regulation of proliferation and protein synthesis by interferons between dermal and oral fibroblasts, and between fibroblasts from palatal granulation tissue and normal palatal tissue.
Our aim now was to determine the effects of interferons on proliferation, collagen synthesis, and non-collagenous protein synthesis of mucoperiosteal granulation and normal fibroblasts.
Section snippets
Interferons
Human recombinant IFN-α2b was obtained from Schering Plough BV (Amstelveen, The Netherlands). Fibroblast-derived human IFN-β was obtained from ICN Pharmaceuticals (Costa Mesa, USA) and rat recombinant IFN-γ was kindly provided by Dr P.H. van der Meide, (BPRC Rijswijk, The Netherlands).
Fibroblast cultures
Five-week-old male Wistar rats were anaesthetized with a subcutaneous injection of 0.4 ml/kg body wt fentanyl+fluanisone (Hypnorm®; Janssen-Cilaq, Beerse, Belgium). A standardized wound was made in the
Collagen and non-collagenous protein synthesis of untreated fibroblasts
Palatal granulation fibroblasts produced significantly 42% more collagen than normal fibroblasts. Although not significant, granulation fibroblasts produced 24% more non-collagenous proteins than normal fibroblasts (Table 1).
Interferon-α2b
Although IFN-α2b tended to reduce the proliferation (Fig. 1A) of granulation and normal fibroblasts by about 10–20%, there were no significant effects. Also, the collagen (Fig. 1B) and non-collagenous protein synthesis (Fig. 1C) of granulation and normal fibroblasts were
Discussion
We have determined the effects of interferons on proliferation, collagen and non-collagenous protein synthesis of granulation-tissue fibroblasts. We have evidence that in this rat model the vast majority of fibroblasts in the granulation tissue are myofibroblasts at 8 days after wounding (A.M.H. Cornelissen et al., unpublished data). Myofibroblasts are involved in wound contraction, matrix synthesis, and remodelling. They have been associated with scar tissue formation (Estes et al., 1994),
Acknowledgements
We are grateful to Dr PH van der Meide (Biomedical Primate Research Centre, Rijswijk, The Netherlands) for the gift of IFN-γ.
References (30)
- et al.
Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro
Journal of the American Academy of Dermatology
(1989) - et al.
Interferon gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms
International Journal of Biochemistry and Cell Biology
(1997) - et al.
Phenotypic and functional features of myofibroblasts in sheep wounds
Differentiation
(1994) - et al.
Healing of experimental excisional wounds in the rat palate. Histological study of the interphase in wound healing after sharp dissection
International Journal of Oral Surgery
(1982) - et al.
Effects of growth factors on mucosal scar fibroblasts in culture—a possible role of growth factors in scar formation
Matrix
(1991) - et al.
Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts
Experimental Cell Research
(1998) - et al.
Mechanisms of tissue repair: from wound healing to fibrosis
International Journal of Biochemical Cell Biology
(1997) - et al.
Differences in interferon α and β signaling
Journal of Biological Chemistry
(1996) - et al.
Interferon gamma regulation of de novo protein synthesis in human dermal fibroblasts in culture is anatomic site dependent
Journal of Investigative Dermatology
(1993) - et al.
General principles of wound healing
Surgical Clinics of North America
(1997)
Immunohistological localisation of growth factors in fetal wound healing
Developmental Biology
Stimulation of human synovial fibroblasts DNA synthesis by recombinant human cytokines
Journal of Rheumatology
Jak-STAT Pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins
Science
The role of the myofibroblasts in wound healing and fibrocontractive diseases
γ Interferon is the lymphokine and β interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation
Journal of Experimental Medicine
Cited by (24)
Medical treatment for pulmonary fibrosis: Current trends, concepts, and prospects
2004, Clinics in Chest MedicineThe interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-γ-induced murine fibroblast proliferation
2002, Journal of Biological ChemistryCitation Excerpt :These observations that mGBP-2 and the GTP-binding mutant show intracellular distributions indistinguishable from the endogenous protein suggest that any differences in the phenotype observed for these cells are not the consequence of gross mistargeting of the respective proteins. Whereas interferons induce an antiproliferative response in many cells, one notable exception is fibroblasts, where IFN-γ treatment can promote primary fibroblast proliferation in vitro (40-46). Consequently, the NIH 3T3 cells expressing mGBP-2 and the GTP-binding mutant were examined for changes in their growth properties.
Antifibrotic therapy for the treatment of pulmonary fibrosis
2001, American Journal of the Medical SciencesCitation Excerpt :Published reports indicate that interferon β can inhibit proliferation of, chemotaxis of, and collagen production by human fibroblasts in vitro. Interferon β was recently reported to reduce the synthesis of collagen, but not noncollagenous proteins, by palatal granulation fibroblasts.69 Furthermore, short-term interferon exposure to cultured scleroderma fibroblasts induced a reduced collagen producing phenotype that was maintained in the absence of interferons.
Recombinant human interferon alpha-2b inhibits the proliferation and migration of scar fibroblasts
2022, Chinese Journal of Tissue Engineering ResearchIFN-α-2b Inhibits the Proliferation and Migration of Fibroblasts via the TGFβ/Smad Signaling Pathway to Reduce Postoperative Epidural Fibrosis
2021, Journal of Interferon and Cytokine Research